Harel Insurance Investments & Financial Services Ltd. Purchases 2,111 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Harel Insurance Investments & Financial Services Ltd. increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 56.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,867 shares of the biotechnology company’s stock after purchasing an additional 2,111 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Axon Enterprise were worth $3,487,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Quent Capital LLC grew its holdings in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC lifted its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. Versant Capital Management Inc boosted its stake in Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Berbice Capital Management LLC bought a new stake in Axon Enterprise during the 4th quarter worth approximately $59,000. Finally, Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise in the third quarter worth approximately $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 2,304 shares of Axon Enterprise stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,545 shares of company stock worth $30,721,337. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $610.32 on Friday. The firm has a 50-day moving average price of $617.65 and a 200-day moving average price of $469.56. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, JMP Securities lifted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.